Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Sector Analysis

Surgical & Medical Instruments & Apparatus

Standard Industrial Classification: SIC 3841

Industry Insider Sentiment Analysis

The Surgical & Medical Instruments & Apparatus sector (SIC 3841) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.

Filing Date Trade Date Ticker Company Reporting Person Relationship Type Price Qty Total, $ Owned After
2024-06-03 23:27 2024-05-30 RCEL AVITA Medical, Inc. O'Toole David D Officer BUY $8.90 1,000 $8,900 19,734
2024-06-03 23:22 2024-05-30 TNDM TANDEM DIABETES CARE INC Allen Dick Director SELL $51.68 5,000 $258,400 0
2024-06-04 04:00 2024-05-30 GKOS GLAUKOS Corp Kliman Gilbert H Director OPT+S $112.00 5,000 $560,000 30,620
2024-06-03 23:30 2024-05-31 TMCI TREACE MEDICAL CONCEPTS, INC. TREACE JAMES T Director BUY $6.05 25,000 $151,328 1,139,441
2024-05-31 23:12 2024-05-30 ATRC AtriCure, Inc. Privitera Salvatore Officer BUY $22.25 5,000 $111,250 103,290
2024-06-01 00:27 2024-05-31 DXCM DEXCOM INC Brown Michael Jon Officer SELL $119.24 652 $77,744 67,560
2024-05-31 01:03 2024-05-30 ICUI ICU MEDICAL INC/DE Voigtlander Christian B. Officer SELL $103.95 12,539 $1,303,484 0
2024-05-30 23:27 2024-05-29 BSX BOSTON SCIENTIFIC CORP Mirviss Jeffrey B. Officer OPT+S $75.10 63,802 $4,791,447 28,022
2024-05-31 00:04 2024-05-29 TMCI TREACE MEDICAL CONCEPTS, INC. TREACE JAMES T Director BUY $5.20 25,000 $130,063 1,114,441
2024-05-30 23:35 2024-05-28 NEPH NEPHROS INC Amron Arthur H Director BUY $2.24 5,000 $11,176 103,463
2024-05-30 20:35 2024-05-29 RVP RETRACTABLE TECHNOLOGIES INC SHAW THOMAS J Director, Officer, 10% owner BUY $0.93 14,282 $13,319 14,489,783
2024-05-30 23:10 2024-05-28 ARAY Accuray Incorporated WHITTERS JOSEPH E Director BUY $1.56 100,000 $156,040 561,053
2024-05-30 00:38 2024-05-29 HAE HAEMONETICS CORP Basil Michelle L Officer SELL $88.08 12,990 $1,144,209 31,257
2024-05-30 00:04 2024-05-28 BSX BOSTON SCIENTIFIC CORP Butcher Arthur C Officer OPT+S $75.34 14,011 $1,055,590 20,197
2024-05-30 00:27 2024-05-29 HAE HAEMONETICS CORP Strong Stewart W Officer SELL $87.53 8,857 $775,253 18,196
2024-05-29 23:33 2024-05-28 TMCI TREACE MEDICAL CONCEPTS, INC. TREACE JAMES T Director BUY $5.07 50,000 $253,475 1,089,441
2024-05-29 23:04 2024-05-28 PODD INSULET CORP Scannell Timothy J Director OPT+S $180.90 3,300 $596,970 42,586
2024-05-28 23:30 2024-05-24 TMCI TREACE MEDICAL CONCEPTS, INC. MOTT RICHARD W Director BUY $5.19 18,000 $93,501 1,072,944
2024-05-24 17:17 2024-05-17 SRTS Sensus Healthcare, Inc. Heinrich John Director SELL $6.17 20,000 $123,416 59,940
2024-05-24 23:08 2024-05-23 IART INTEGRA LIFESCIENCES HOLDINGS CORP ESSIG STUART Director, Officer BUY $28.49 52,641 $1,499,979 487,922
2024-05-24 16:54 2024-05-22 RVP RETRACTABLE TECHNOLOGIES INC SHAW THOMAS J Director, Officer, 10% owner BUY $0.88 32,752 $28,884 14,475,501
2024-05-23 23:11 2024-05-21 BSX BOSTON SCIENTIFIC CORP Brown Vance R Officer OPT+S $75.79 33,043 $2,504,240 32,326
2024-05-23 23:06 2024-05-22 SYK STRYKER CORP Fletcher Robert S Officer SELL $332.99 2,007 $668,308 8,896
2024-05-23 23:12 2024-05-22 BSX BOSTON SCIENTIFIC CORP Brennan Daniel J. Officer OPT+S $75.57 112,075 $8,469,754 223,921
2024-05-24 01:07 2024-05-23 INFU InfuSystem Holdings, Inc BOYD RALPH F JR Director BUY $7.13 4,000 $28,520 6,000
2024-05-24 01:03 2024-05-22 INFU InfuSystem Holdings, Inc HUSS BEVERLY A Director BUY $6.86 4,300 $29,486 4,300
2024-05-23 23:30 2024-05-22 TMCI TREACE MEDICAL CONCEPTS, INC. MOTT RICHARD W Director BUY $4.99 12,100 $60,425 1,054,944
2024-05-24 01:07 2024-05-22 LUNG Pulmonx Corp Rose Geoffrey Beran Officer SELL $8.71 1,184 $10,313 305,500
2024-05-22 21:07 2024-05-20 PLSE PULSE BIOSCIENCES, INC. Barrett Burke Thomas Director, Officer BUY $8.56 10,000 $85,600 10,000
2024-05-23 02:38 2024-05-20 PEN Penumbra Inc Elsesser Adam Director, Officer SELL $200.98 15,000 $3,014,735 942,582
2024-05-22 23:09 2024-05-21 IART INTEGRA LIFESCIENCES HOLDINGS CORP HILL BARBARA B Director BUY $27.40 36,350 $995,816 36,350
2024-05-22 21:51 2024-05-21 RVP RETRACTABLE TECHNOLOGIES INC SHAW THOMAS J Director, Officer, 10% owner BUY $0.90 20,000 $18,016 14,442,749
2024-05-22 00:52 2024-05-17 HAE HAEMONETICS CORP Llorens Josep Officer SELL $94.96 1,809 $171,786 21,310
2024-05-22 00:46 2024-05-17 HAE HAEMONETICS CORP Basil Michelle L Officer SELL $95.05 2,677 $254,443 31,257
2024-05-22 00:59 2024-05-17 SSII SS Innovations International, Inc. Cohen Barry F Director, Officer BUY $3.31 2,871 $9,489 8,956,855
2024-05-22 01:01 2024-05-20 HAE HAEMONETICS CORP Strong Stewart W Officer OPT+S $95.11 686 $65,245 18,196
2024-05-22 01:17 2024-05-20 INFU InfuSystem Holdings, Inc Funke Jerod Officer BUY $6.39 1,000 $6,388 1,000
2024-05-22 01:14 2024-05-21 INFU InfuSystem Holdings, Inc Chupa Addam Officer BUY $6.67 1,000 $6,670 24,774
2024-05-22 01:09 2024-05-20 INFU InfuSystem Holdings, Inc GENDRON PAUL ANDREW Director BUY $6.54 5,000 $32,700 65,000
2024-05-22 01:24 2024-05-20 INFU InfuSystem Holdings, Inc Steele Barry G Officer BUY $6.47 3,000 $19,398 70,195
2024-05-22 04:15 2024-05-16 OBIO Orchestra BioMed Holdings, Inc. Hochman David P Director, Officer BUY $4.99 5,000 $24,950 332,502
2024-05-21 22:14 2024-05-20 AURX Nuo Therapeutics, Inc. SHEEDY CHARLES E 10% owner BUY $0.75 100,000 $75,000 11,312,500
2024-05-20 23:30 2024-05-17 TMCI TREACE MEDICAL CONCEPTS, INC. Treace John T. Director, Officer, 10% owner BUY $5.56 100,000 $556,170 6,343,095
2024-05-21 03:56 2024-05-17 SGHT Sight Sciences, Inc. Bauerlein Alison Officer SELL $5.42 13,066 $70,870 413,182
2024-05-21 00:57 2024-05-16 RVP RETRACTABLE TECHNOLOGIES INC SHAW THOMAS J Director, Officer, 10% owner BUY $1.03 54,236 $55,863 14,422,749
2024-05-20 23:35 2024-05-16 LMAT LEMAITRE VASCULAR INC Ross Bridget A Director OPT+S $77.99 5,500 $428,945 2,278
2024-05-20 23:36 2024-05-16 TCMD TACTILE SYSTEMS TECHNOLOGY INC Birkemeyer Elaine M. Officer SELL $13.68 3,041 $41,590 61,295
2024-05-17 18:27 2024-05-15 RMD RESMED INC De Witte Jan Director SELL $218.29 360 $78,584 7,519
2024-05-17 23:55 2024-05-16 HAE HAEMONETICS CORP Llorens Josep Officer SELL $96.14 770 $74,028 17,172
2024-05-18 00:02 2024-05-16 HAE HAEMONETICS CORP Basil Michelle L Officer SELL $96.14 985 $94,698 30,425
SHOW ENTRIES

Sector-Wide Insider Alpha

Analyzing insider movements across the Surgical & Medical Instruments & Apparatus sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (3841) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.

SEC Filings in Surgical & Medical Instruments & Apparatus

Every transaction in the Surgical & Medical Instruments & Apparatus industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.